EcoDrugPlus

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSCAFG00020008843
Gene Symbol: PSMA3
3 Cross references
244 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSCAFG00020021060
Gene Symbol: PSMA4
2 Cross references
227 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSCAFG00020010013
Gene Symbol: PSMA5
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSCAFG00020023389
Gene Symbol: PSMA6
2 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSCAFG00020022159
Gene Symbol: PSMA7
3 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSCAFG00020013698
Gene Symbol: PSMA8
3 Cross references
198 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSCAFG00020019862
Gene Symbol: PSMB1
3 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSCAFG00020018533
Gene Symbol: PSMB10
3 Cross references
172 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSCAFG00020009927
Gene Symbol: PSMB2
3 Cross references
221 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSCAFG00020023019
Gene Symbol: PSMB3
2 Cross references
221 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSCAFG00020012881
Gene Symbol: PSMB4
3 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Beta 5

Ensembl ID : ENSCAFG00020007663
Gene Symbol: PSMB5
3 Cross references
221 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).